Quantbot Technologies’s Cerevel Therapeutics Holdings CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-8,647
Closed -$273K – 2170
2022
Q4
$273K Buy
+8,647
New +$244K 0.02% 786
2022
Q1
– Sell
-2,300
Closed -$74K – 2151
2021
Q4
$74K Buy
2,300
+1,200
+109% +$42.3K 0.01% 942
2021
Q3
$32K Buy
+1,100
New +$30.9K ﹤0.01% 1190

Other funds holding CERE

Quantbot Technologies's CERE Position: Q1 2023 in Review

Quantbot Technologies sold out of Cerevel Therapeutics Holdings (CERE) in Q1 2023, closing a stake of 8,647 shares — an estimated $273K sold.

Quantbot Technologies first reported a position in CERE in Q3 2021 and held it in 3 quarters. The position peaked at $273K in Q4 2022. 119 funds tracked by Wall St. Rank hold CERE as of Q1 2023.

  • Quantbot Technologies reported no remaining Cerevel Therapeutics Holdings position as of Q1 2023 after selling out during the quarter.
  • Quantbot Technologies sold 8,647 Cerevel Therapeutics Holdings shares in Q1 2023, an estimated $273K.
  • Quantbot Technologies first reported a position in Cerevel Therapeutics Holdings in Q3 2021 and held it in 3 quarters.
  • Quantbot Technologies's Cerevel Therapeutics Holdings position peaked at $273K in Q4 2022.
  • 119 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings as of Q1 2023.

Based on Quantbot Technologies's 13F filing for Q1 2023, filed 12 May 2023.